Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis

被引:0
|
作者
Jiu, Li [1 ]
Hartog, Michiel [1 ]
Wang, Junfeng [1 ]
Vreman, Rick A. [1 ]
Klungel, Olaf H. [1 ]
Mantel-Teeuwisse, Aukje K. [1 ]
Goettsch, Wim G. [1 ,2 ]
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[2] Natl Hlth Care Inst, Diemen, Netherlands
来源
BMJ OPEN | 2024年 / 14卷 / 02期
关键词
Systematic Review; EPIDEMIOLOGY; HEALTH ECONOMICS; SYSTEMATIC REVIEWS; REPORTING QUALITY; PUBLIC-HEALTH; RISK; CARE; BIAS; REPRODUCIBILITY; RECOMMENDATIONS; COMPLEMENTARY; APPRAISAL;
D O I
10.1136/bmjopen-2023-075173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We aimed to identify existing appraisal tools for non-randomised studies of interventions (NRSIs) and to compare the criteria that the tools provide at the quality-item level.Design Literature review through three approaches: systematic search of journal articles, snowballing search of reviews on appraisal tools and grey literature search on websites of health technology assessment (HTA) agencies.Data sources Systematic search: Medline; Snowballing: starting from three articles (D'Andrea et al, Quigley et al and Faria et al); Grey literature: websites of European HTA agencies listed by the International Network of Agencies for Health Technology Assessment. Appraisal tools were searched through April 2022.Eligibility criteria for selecting studies We included a tool, if it addressed quality concerns of NRSIs and was published in English (unless from grey literature). A tool was excluded, if it was only for diagnostic, prognostic, qualitative or secondary studies.Data extraction and synthesis Two independent researchers searched, screened and reviewed all included studies and tools, summarised quality items and scored whether and to what extent a quality item was described by a tool, for either methodological quality or reporting.Results Forty-nine tools met inclusion criteria and were included for the content analysis. Concerns regarding the quality of NRSI were categorised into 4 domains and 26 items. The Research Triangle Institute Item Bank (RTI Item Bank) and STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) were the most comprehensive tools for methodological quality and reporting, respectively, as they addressed (n=20; 17) and sufficiently described (n=18; 13) the highest number of items. However, none of the tools covered all items.Conclusion Most of the tools have their own strengths, but none of them could address all quality concerns relevant to NRSIs. Even the most comprehensive tools can be complemented by several items. We suggest decision-makers, researchers and tool developers consider the quality-item level heterogeneity, when selecting a tool or identifying a research gap.OSF registration number OSF registration DOI (https://doi.org/10.17605/OSF.IO/KCSGX).
引用
收藏
页数:15
相关论文
共 50 条
  • [41] The Mortality from Hereditary Angioedema Worldwide: a Review of the Real-World Data Literature
    Fernanda Gontijo Minafra
    Tifany Rafaely Gonçalves
    Thaís Martins Alves
    Jorge Andrade Pinto
    Clinical Reviews in Allergy & Immunology, 2022, 62 : 232 - 239
  • [42] What is real-world data? A review of definitions based on literature and stakeholder interviews
    Makady, Amr
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 410 - 410
  • [43] 'Real-world' health care priority setting using explicit decision criteria: a systematic review of the literature
    Cromwell, Ian
    Peacock, Stuart J.
    Mitton, Craig
    BMC HEALTH SERVICES RESEARCH, 2015, 15
  • [44] ‘Real-world’ health care priority setting using explicit decision criteria: a systematic review of the literature
    Ian Cromwell
    Stuart J Peacock
    Craig Mitton
    BMC Health Services Research, 15
  • [45] Assessing transport network resilience: empirical insights from real-world data studies
    Bergantino, Angela Stefania
    Gardelli, Alessandro
    Rotaris, Lucia
    TRANSPORT REVIEWS, 2024, 44 (04) : 834 - 857
  • [46] The Certainty Framework for Assessing Real-World Data in Studies of Medical Product Safety and Effectiveness
    Cocoros, Noelle M.
    Arlett, Peter
    Dreyer, Nancy A.
    Ishiguro, Chieko
    Iyasu, Solomon
    Sturkenboom, Miriam
    Zhou, Wei
    Toh, Sengwee
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (05) : 1189 - 1196
  • [47] A COST AND OUTCOMES ANALYSIS OF RENAL REPLACEMENT THERAPIES USING REAL-WORLD QUALITY OF LIFE DATA
    Nagaraja, Pramod
    Lodhi, Vikas
    Garrell, David
    Roberts, Gareth
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [48] Digital health program improves quality of life in rheumatoid arthritis: a retrospective analysis of real-world data
    Dobies, B.
    White, A. J.
    Isberg, A.
    Gudmundsson, S. F.
    Oddsson, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (01) : 10 - 14
  • [49] Assessing the practice of data quality evaluation in a national clinical data research network through a systematic scoping review in the era of real-world data
    Bian, Jiang
    Lyu, Tianchen
    Loiacono, Alexander
    Viramontes, Tonatiuh Mendoza
    Lipori, Gloria
    Guo, Yi
    Wu, Yonghui
    Prosperi, Mattia
    George, Thomas J., Jr.
    Harle, Christopher A.
    Shenkman, Elizabeth A.
    Hogan, William
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2020, 27 (12) : 1999 - 2010
  • [50] Investigating long-term complications of gestational diabetes using real-world data
    Goldet, G.
    Tam, F.
    Frankel, A.
    Ul-Haq, Z.
    Dattani, R.
    Kamalati, T.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S193 - S193